Graphite Bio Alternatives & Competitors
12 companies similar to Graphite Bio — Creating a future where the word 'incurable' no longer exists.
Companies similar to Graphite Bio
Editas Medicine
What If You Could Repair Broken Genes?
Prime Medicine, Inc.
Delivering on the promise of Prime Editing
Acrigen Biosciences
Developing life-saving genetic therapies using our proprietary precision gene editing tech...
Specific Biologics
DEVELOPING NEXT GENERATION GENE EDITING TECHNOLOGIES
Rival Readout
Competing with Graphite Bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Caribou Biosciences
Clinical-stage biopharmaceutical company developing transformative therapies to treat deva...
Vera Therapeutics, Inc.
We are a clinical-stage biotechnology company developing treatments that transform patient...
Tessera Therapeutics
Pioneering the future of genetic medicine with the power to rewrite the genome and cure di...
SonoThera
SonoThera is developing ultrasound-mediated nonviral genetic therapies.
Laverock Therapeutics
Programmable advanced therapies
Tune Therapeutics
Mastering the epigenome, unlocking complex disease.
Century Therapeutics, Inc
Advancing iPSC-derived cell therapies to transform care in autoimmune disease and cancer
About Graphite Bio
Graphite Bio, founded in 2020 and headquartered in the United States, is a clinical-stage biotechnology company revolutionizing the field of gene editing. The company aims to eliminate the term "incurable," as captured by their slogan, "Creating a future where the word 'incurable' no longer exists." Graphite Bio is pio...
Development and commercialization of VIZZ ophthalmologic solution, Providing pharmaceutical solutions for presbyopia
Individuals with presbyopia, Healthcare professionals specializing in ophthalmology, Optometrists, Ophthalmologists
Gene Editing, Precision Medicine, CRISPR Technology, Homology-directed Repair, Gene Therapy, Genome Correction, Sickle Cell Disease, DNA Repair, Disease Cure, Clinical-stage Biotechnology, Therapeutic Innovation, Novel Conditioning Regimens, Genetic Mutations, Next-generation Therapies
B2B, D2C, B2D
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Graphite Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Graphite Bio on 11 Mar 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.